| F |
Report |
Adjusted EPS |
BEAT |
pred ~$0.34 vs. cons $0.33 |
MEDIUM |
| F |
Report |
Ford Pro adjusted EBIT |
MISS |
pred ~$1.60B vs. cons $1.68B |
MEDIUM |
| F |
Report |
Model e adjusted EBIT |
MISS |
pred ~$(1.31)B vs. cons $(1.26)B |
MEDIUM |
| F |
Guide |
Adjusted EBIT |
UNCHANGED |
guide ~$9.50B midpoint vs. cons $9.55B (FY2026) |
HIGH |
| F |
Guide |
Adjusted free cash flow |
UNCHANGED |
guide ~$5.50B midpoint vs. cons $5.50B (FY2026) |
MEDIUM |
| F |
Guide |
Ford Pro adjusted EBIT |
UNCHANGED |
guide ~$7.00B midpoint vs. cons $7.00B (FY2026) |
MEDIUM |
| F |
Guide |
Novelis-related production recovery |
UNCHANGED |
guide ~150K units vs. cons 150K units (FY2026) |
MEDIUM |
| F |
Return |
Day-1 residual (stock − beta × S&P 500) |
-3.4% |
— |
MEDIUM |
| F |
Return |
5-day cumulative residual |
-5.1% (FOLLOW-THROUGH) |
A small EPS beat is likely to be judged low quality if Ford Pro and Model e miss while FY2026 guidance remains unchanged. The unchanged $9.50B EBIT midpoint after a strong Q1 implies only about $4.1B of second-half EBIT versus roughly $4.3B embedded in consensus, driving estimate cuts after the initial reaction. |
MEDIUM |